These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1910082)
1. HIV antigen variability in ARC/AIDS. Hendrix CW; Volberding PA; Chaisson RE J Acquir Immune Defic Syndr (1988); 1991; 4(9):847-50. PubMed ID: 1910082 [TBL] [Abstract][Full Text] [Related]
2. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651 [TBL] [Abstract][Full Text] [Related]
3. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115 [TBL] [Abstract][Full Text] [Related]
4. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial. Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098 [TBL] [Abstract][Full Text] [Related]
5. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. Richman DD; Grimes JM; Lagakos SW J Acquir Immune Defic Syndr (1988); 1990; 3(8):743-6. PubMed ID: 2114476 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection. Croxson TS; Mathur-Wagh U; Handwerger S; Siroty WE; Kaminisky D; Reagan KJ; Yancovitz SR; Mildvan D AIDS Res Hum Retroviruses; 1990 Apr; 6(4):455-63. PubMed ID: 2111160 [TBL] [Abstract][Full Text] [Related]
7. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS. Reddy MM; McKinley G; Englard A; Grieco MH J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599 [TBL] [Abstract][Full Text] [Related]
8. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex. Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778 [TBL] [Abstract][Full Text] [Related]
9. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine. Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627 [TBL] [Abstract][Full Text] [Related]
10. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects. Mulder JW; de Wolf F; Goudsmit J; Cload PA; Coutinho RA; Fiddian AP; Schellekens PT; van der Noordaa J; Lange JM Antiviral Res; 1990 Mar; 13(3):127-38. PubMed ID: 1972321 [TBL] [Abstract][Full Text] [Related]
12. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. Dis Markers; 1990; 8(3):159-61. PubMed ID: 2125536 [No Abstract] [Full Text] [Related]
14. Plasma viremia in human immunodeficiency virus infection. Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447 [TBL] [Abstract][Full Text] [Related]
15. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience. Stambuk D; Hawkins D; Gazzard BG J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585 [TBL] [Abstract][Full Text] [Related]
16. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS. Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859 [TBL] [Abstract][Full Text] [Related]
17. Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection. Ohlsson-Wilhelm BM; Cory JM; Kessler HA; Eyster ME; Rapp F; Landay A J Infect Dis; 1990 Nov; 162(5):1018-24. PubMed ID: 1977803 [TBL] [Abstract][Full Text] [Related]
18. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205 [TBL] [Abstract][Full Text] [Related]
19. Virological examinations of patients with AIDS-related complex/Walter-Reed 5 enrolled in a double-blind placebo-controlled study with intravenous gammaglobulin administration. Prognostic value of anti-p24 determination. The ARC-IVIG Study Group. Mertens T; Ramon A; Kruppenbacher JP; Heitmann K; Pika U; Leyssens N; Lievens M Vox Sang; 1990; 59 Suppl 1():21-9. PubMed ID: 1700551 [TBL] [Abstract][Full Text] [Related]
20. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. Collier AC; Bozzette S; Coombs RW; Causey DM; Schoenfeld DA; Spector SA; Pettinelli CB; Davies G; Richman DD; Leedom JM N Engl J Med; 1990 Oct; 323(15):1015-21. PubMed ID: 1977080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]